Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for G 2/21
Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23) Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23) Reviewed by Dr Rose Hughes on Wednesday, October 29, 2025 Rating: 5
Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy Reviewed by Dr Rose Hughes on Tuesday, May 27, 2025 Rating: 5
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 Reviewed by Annsley Merelle Ward on Friday, May 09, 2025 Rating: 5
Stretching the cheese: Contradictory evidence for a purported technical effect relied on for inventive step (T 0629/22) Stretching the cheese: Contradictory evidence for a purported technical effect relied on for inventive step (T 0629/22) Reviewed by Dr Rose Hughes on Monday, May 13, 2024 Rating: 5
Petition for review filed in referring decision to G2/21 (T 0116/18) Petition for review filed in referring decision to G2/21 (T 0116/18) Reviewed by Dr Rose Hughes on Sunday, January 28, 2024 Rating: 5
Crystallising the interpretation of G 2/21 (T 1989/19) Crystallising the interpretation of G 2/21 (T 1989/19) Reviewed by Dr Rose Hughes on Thursday, December 21, 2023 Rating: 5
Clarity on the interpretation of G2/21 from the referring Board (T 0116/18) Clarity on the interpretation of G2/21 from the referring Board (T 0116/18) Reviewed by Dr Rose Hughes on Monday, November 27, 2023 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.